Table 1. Summary of hematologic... | American Society of Hematology

Table 1.

Summary of hematologic responses to 5-aza-CdR

Patient	Dose	HbF %		F cells %		γ/β + γ		Hb g/dL		Neutrophils
Patient	Dose	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Nadir
1	0.15	2.3	9.6	25	49	3.3	9.4	7.3	8.1	2.7	1.7
	0.25		10.7		48		13.1	7.4	8.5	4.0	0.7
2	0.15	4.3	12.4			2.4	13.7	8.5	9.6	7.0	0.7
	0.25		15				22.0	8.7	10.0	6.3	0.3
3	0.20	0.9	11.3	8	51	1.6	11.6	7.7	9.3	9.6	3.8
	0.30		13.9		54		12.5	8.6	9.0	7.8	2.1
4	0.20	0.5	8.6	3	36	<1.0	10.1	7.5	8.6	12.1	2.9
	0.30		11.2		47		12.0	8.5	9.0	12.5	2.3
5	0.15	3.4	9.5	18	51	3.4	6.4	NA	NA	NA	NA
	0.25		13.1		56		14.4	8.8	9.4	4.5	1.8
6	0.15	4.3	15.9			5.0	12.4	8.8	10.6	5.4	2.8
7	0.20	3.4	18.8	28	77	4.1	14.7	9.2	9.5	4.3	1.6
	0.30		20.2		74		17.0	8.5	10.1	5.0	0.4
8	0.15	8.3	18.1	44	76	4.7	22.0	8.6	9.1	3.7	1.8
$\bar{X}$ ± SD		3.6 ± 2.4	13.5 ± 3.7	21 ± 14.8	55.3 ± 13.5	3.2 ± 1.4	13.7 ± 4.4	8.3 ± 0.6	9.3 ± 0.7^*	6.2 ± 2.9	1.4 ± 1.0

Patient	Dose	HbF %		F cells %		γ/β + γ		Hb g/dL		Neutrophils
Patient	Dose	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Nadir
1	0.15	2.3	9.6	25	49	3.3	9.4	7.3	8.1	2.7	1.7
	0.25		10.7		48		13.1	7.4	8.5	4.0	0.7
2	0.15	4.3	12.4			2.4	13.7	8.5	9.6	7.0	0.7
	0.25		15				22.0	8.7	10.0	6.3	0.3
3	0.20	0.9	11.3	8	51	1.6	11.6	7.7	9.3	9.6	3.8
	0.30		13.9		54		12.5	8.6	9.0	7.8	2.1
4	0.20	0.5	8.6	3	36	<1.0	10.1	7.5	8.6	12.1	2.9
	0.30		11.2		47		12.0	8.5	9.0	12.5	2.3
5	0.15	3.4	9.5	18	51	3.4	6.4	NA	NA	NA	NA
	0.25		13.1		56		14.4	8.8	9.4	4.5	1.8
6	0.15	4.3	15.9			5.0	12.4	8.8	10.6	5.4	2.8
7	0.20	3.4	18.8	28	77	4.1	14.7	9.2	9.5	4.3	1.6
	0.30		20.2		74		17.0	8.5	10.1	5.0	0.4
8	0.15	8.3	18.1	44	76	4.7	22.0	8.6	9.1	3.7	1.8
$\bar{X}$ ± SD		3.6 ± 2.4	13.5 ± 3.7	21 ± 14.8	55.3 ± 13.5	3.2 ± 1.4	13.7 ± 4.4	8.3 ± 0.6	9.3 ± 0.7^*	6.2 ± 2.9	1.4 ± 1.0